Clinical trial · Interventional
Pancreas Cancer Surveillance Using an Abbreviated MRI
Clinical Feasibility of Abbreviated MRI for Surveillance in High Risk Group for Developing Pancreas Cancer: A Prospective Cohort Study
NCT04592393CI-TRIAL-00068884active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Abbreviated PB MRI | Diagnostic Test | — | UNRESOLVED |
| Conventional follow-up | Diagnostic Test | — | UNRESOLVED |
| Gene mutation test | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Abbreviated PB MRI
- description
- Short and Focused non-contrast MRI for surveillance
- interventionNames
- Diagnostic Test: Abbreviated PB MRI
- Genetic: Gene mutation test
- Diagnostic Test: Conventional follow-up
Primary outcomes (1)
- measure
- Detection of pancreas cancer
- timeFrame
- 1 year after the last surveillance MRI.
- description
- number of detected pancreas cancer (resectable \& BRPC only) in surveillance MRI.
Secondary outcomes (3)
- measure
- Scan time of abbreviated PB MRI for surveillance
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * On follow-up due to first degree-family history of PAC * Or on follow-up for BD-IPMN (\>= 2 cm) or main-duct type IPMN (\> 5 mm) * And signed informed consent Exclusion Criteria: * Contra-indication of performing MRI * Not satisfying the selection criteria. * Previously diagnosed with pancreatic malignancy * Pregnancy or planning pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.